Z4. COVID-19 Treatment
Poster Session: COVID-19: Treatment
Essy Mozaffari, PharmD, MPH, MBA
Senior Director
Gilead Sciences
Foster, California, United States
Aastha Chandak, PhD
Senior Manager, Head US Statistics
Certara
New York, New York, United States
Robert L. Gottlieb, MD
Practicing Physician
Baylor University Medical Center
Dallas, Texas, United States
Chidinma Chima-Melton, MD
University of California Los Angeles
Los Angeles, California, United States
Mark Berry, PhD (he/him/his)
Director, epidemiology
Gilead Sciences, Inc.
Foster City, California, United States
Thomas F. Oppelt, PharmD, BCPS
Sr. Director, Medical Affairs
Gilead Sciences, Inc
Foster City, California, United States
Jason F. Okulicz, MD
Gilead Sciences, Inc.
Foster City, New Jersey, United States
Alpesh N. Amin, MD, MBA
University of California, Irvine
Orange, California, United States
Paul E. Sax, MD
Clinical Director, Division of Infectious Diseases; Professor of Medicine
Brigham and Women’s Hospital; Harvard Medical School
Boston, MA, United States
Andre Kalil, MD, MPH
Professor
University of Nebraska Medical Center, United States